Bruce Ovbiagele1, Robert J Adams. 1. Department of Neurosciences, University of California, San Diego, CA 92093, USA. Ovibes@ucsd.edu
Abstract
BACKGROUND: Stroke is a major complication of sickle cell disease (SCD). In an era of chronic red cell transfusions for stroke prophylaxis in children and greater life expectancy, nationwide data on stroke rates among pediatric and adult patients with SCD are scarce. We evaluated recent time trends in stroke hospitalization among children (0-17 years) and adults (>17 years) with SCD in the United States. METHODS: Data were obtained from the Nationwide Inpatient Sample. Pediatric (n=26,380) and adult (n=9,638,507) patients admitted to hospitals between 1997 and 2006 with a primary stroke discharge diagnosis (identified by the International Classification of Diseases, Ninth Revision procedure codes) were included. Time trends in the proportion of stroke patients with SCD were computed. RESULTS: Pediatric stroke patients with co-morbid SCD constituted 8.7% in 1997 vs. 4.8% in 2006 (p=0.04), with 81 fewer actual hospitalizations. Adult stroke patients with SCD were 0.3% in 1997 vs. 0.5% in 2006 (p=0.01), with 157 more actual hospitalizations. Factors that changed substantially and significantly across the decade among pediatric stroke patients with SCD included a drop in ischemic stroke type (74.2% vs. 56.3%) and a rise in comorbid hypertension (1.5% vs. 11.5%), while among adult stroke patients with SCD there was a rise in other stroke type (20.4% vs. 35.6%). CONCLUSIONS: In an era of increasing prophylactic red cell transfusions, the proportion of SCD diagnoses among pediatric stroke patients significantly decreased in the United States. The rise in SCD diagnoses among adult stroke patients is possibly due to a cohort effect, but further study is needed.
BACKGROUND:Stroke is a major complication of sickle cell disease (SCD). In an era of chronic red cell transfusions for stroke prophylaxis in children and greater life expectancy, nationwide data on stroke rates among pediatric and adult patients with SCD are scarce. We evaluated recent time trends in stroke hospitalization among children (0-17 years) and adults (>17 years) with SCD in the United States. METHODS: Data were obtained from the Nationwide Inpatient Sample. Pediatric (n=26,380) and adult (n=9,638,507) patients admitted to hospitals between 1997 and 2006 with a primary stroke discharge diagnosis (identified by the International Classification of Diseases, Ninth Revision procedure codes) were included. Time trends in the proportion of strokepatients with SCD were computed. RESULTS:Pediatric strokepatients with co-morbid SCD constituted 8.7% in 1997 vs. 4.8% in 2006 (p=0.04), with 81 fewer actual hospitalizations. Adult strokepatients with SCD were 0.3% in 1997 vs. 0.5% in 2006 (p=0.01), with 157 more actual hospitalizations. Factors that changed substantially and significantly across the decade among pediatric strokepatients with SCD included a drop in ischemic stroke type (74.2% vs. 56.3%) and a rise in comorbid hypertension (1.5% vs. 11.5%), while among adult strokepatients with SCD there was a rise in other stroke type (20.4% vs. 35.6%). CONCLUSIONS: In an era of increasing prophylactic red cell transfusions, the proportion of SCD diagnoses among pediatric strokepatients significantly decreased in the United States. The rise in SCD diagnoses among adult strokepatients is possibly due to a cohort effect, but further study is needed.
Authors: Charlotte Baker; Althea M Grant; Mary G George; Scott D Grosse; Thomas V Adamkiewicz Journal: Pediatr Blood Cancer Date: 2015-07-14 Impact factor: 3.167
Authors: James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson Journal: Stroke Date: 2014-10-28 Impact factor: 7.914
Authors: Robert J Adams; Dan T Lackland; Lynette Brown; David Brown; Jenifer Voeks; Heather J Fullerton; Julie Kanter; Janet L Kwiatkowski Journal: Am J Hematol Date: 2016-10-25 Impact factor: 10.047
Authors: Sarah Reeves; Erika Garcia; Mary Kleyn; Michelle Housey; Robin Stottlemyer; Sarah Lyon-Callo; Kevin John Dombkowski Journal: Acad Pediatr Date: 2014-05-29 Impact factor: 3.107
Authors: Robert J Adams; Rufus O Akinyemi; Mayowa O Owolabi; Dan L Lackland; Bruce Ovbiagele Journal: J Clin Hypertens (Greenwich) Date: 2018-05-27 Impact factor: 3.738
Authors: Juan C Kupferman; Marc B Lande; Stella Stabouli; Dimitrios I Zafeiriou; Steven G Pavlakis Journal: Pediatr Nephrol Date: 2020-04-29 Impact factor: 3.714